AstraZeneca expressed regret over the European Commission’s decision to launch legal action against it over breaches of Coronavirus (COVID-19) vaccine doses supply contract.
The company insisted in a statement on Monday that it was in full compliance with the agreement.
“AstraZeneca regrets the European Commission’s decision to take legal action over the supply of COVID-19 vaccines… Our company is about to deliver almost 50 million doses to European countries by the end of April, in line with our forecast.
“AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court.
“We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible,” the company said.
AstraZeneca added that it remains committed to constructive cooperation with the commission “to vaccinate as many people as possible.”